第 5 節　激素及影響內分泌機轉藥物

Hormones & drugs affecting hormonal mechanism

• 5.1糖尿病用藥 Drugs used in diabetes
  • 5.1.1Acarbose如 Glucobay、Diaban98/12/1
  • 5.1.2Guar gum如 Guarina、Guarem
  • 5.1.3GLP-1受體促效劑108/7/1
    • 5.1.3.1Exenatide如 Byetta107/4/1
    • 5.1.3.2Liraglutide如 Victoza、Trulicity、Lyxumia、Ozempic109/12/1
    • 5.1.3.3含lixisenatide及insulin glargine之複方製劑如 Soliqua110/7/1
  • 5.1.4(刪除)107/10/1
  • 5.1.5SGLT-2抑制劑及其複方
  • 5.1.6含empagliflozin及linagliptin之複方製劑如 Glyxambi109/5/1
  • 5.1.7含dapagliflozin及saxagliptin之複方製劑如 Qtern109/5/1
  • 5.1.8含ertugliflozin及sitagliptin之複方製劑如 Steglujan109/5/1
• 5.2雄性激素類製劑與同化作用類固醇及其拮抗劑 Androgens and anabolic steroids and antagonists
  • 5.2.1Danazol限下列病例使用86/1/1
  • 5.2.2含testosterone 5-alpha reductase inhibitor製劑101/3/1
    • 5.2.2.1Finasteride如 Proscar、Avodart108/12/1
    • 5.2.2.2Dutasteride + tamsulosin如 Duodart108/12/1
• 5.3動情激素、黃體激素及治療不孕症藥物  Estrogens, progestins & drugs used for infertility
  • 5.3.1Estradiol之經皮吸收製劑
    • 5.3.1.1Estraderm TTS；Oestro V.T93/5/1
    • 5.3.1.2Estradiol 3.8mg/12.5cm2/patch如 Climara 50 Transdermal Patch90/4/1
  • 5.3.2FSH (pure FSH)用於誘發排卵時，限hypothalamus failure (下視丘功能衰竭)患者，事前專案報准後使用85/1/1
  • 5.3.3HMG用於誘發排卵時，限hypothalamus failure (下視丘功能衰竭)患者，事前專案報准後使用85/1/1
  • 5.3.4(刪除)110/12/1
  • 5.3.5Levonorgestrel intrauterine system如 Mirena107/4/1
  • 5.3.6Megestrol口服液劑109/3/1
• 5.4作用於腦下腺前葉與下視丘的藥物 Drugs related to anterior pituitary & hypothalamic function
  • 5.4.1.1生長激素 (Somatropin)111/2/1
  • 5.4.1.2生長激素如 Genotropin106/8/1
  • 5.4.2Bromocriptine
  • 5.4.3Octreotide inj如 Sandostatin inj102/1/1
  • 5.4.4Octreotide長效型注射劑如 Sandostatin LAR Microspheres for Injection104/4/1
  • 5.4.5Somatostatin89/5/1
  • 5.4.6Lanreotide如 Somatuline106/8/1
  • 5.4.7Cabergoline如 Dostinex Tab.91/6/1
  • 5.4.8Pasireotide如 Signifor106/10/1
  • 5.4.9Pasireotide長效緩釋注射劑如 Signifor LAR108/12/1
• 5.5其他 Miscellaneous
  • 5.5.1Gn-RH analogue如 Buserelin、Goserelin、Leuprorelin、Triptorelin、Nafarelin(acetate113/6/1
    • 5.5.1.1Degarelix如 Firmagon103/9/1
  • 5.5.2抑鈣激素製劑 (Salmon calcitonin injection)
  • 5.5.3Bisphosphonate
    • 5.5.3.1Clodronate；pamidronate100/1/1
    • 5.5.3.2Zoledronic acid98/6/1
      • 5.5.3.2.1Zoledronic acid 4mg/vial如 Zometa Powder For Solution For Infusion 4mg100/1/1
      • 5.5.3.2.2Zoledronic acid 5mg如 Aclasta 5mg、100mL Solution for infusion100/1/1
    • 5.5.3.3Etidronate如 Etibon100/1/1
    • 5.5.3.4Ibandronic acid100/1/1
      • 5.5.3.4.1Ibandronic acid 2mg/2mL；6mg/6mL如 Bondronat concentrate for solution for infusion100/1/1
  • 5.5.4Denosumab如 Xgeva113/10/1
  • 5.5.6Rasburicase如 Fasturtec注射劑93/5/1
  • 5.5.7Mecasermin如 Increlex注射劑111/2/1
  • 5.5.8Vosoritide如 Voxzogo114/5/1
• 5.6骨質疏鬆症治療藥物100/1/1
  • 5.6.1抗骨質再吸收劑（anti- resorptive）115/9/1
  • 5.6.2Parathyroid hormones and analogues （副甲狀腺素及類似劑）110/5/1
  • 5.6.3Romosozumab如 Evenity115/8/1